Keith Davison

1.1k total citations
9 papers, 665 citations indexed

About

Keith Davison is a scholar working on Molecular Biology, Cell Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Keith Davison has authored 9 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cell Biology and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Keith Davison's work include Muscle Physiology and Disorders (6 papers), Calpain Protease Function and Regulation (4 papers) and Biotin and Related Studies (2 papers). Keith Davison is often cited by papers focused on Muscle Physiology and Disorders (6 papers), Calpain Protease Function and Regulation (4 papers) and Biotin and Related Studies (2 papers). Keith Davison collaborates with scholars based in United Kingdom, Germany and France. Keith Davison's co-authors include Louise V.B. Anderson, Clarke R. Slater, John B. Harris, L. V. B. Nicholson, Colin R. Harwood, Elizabeth O’Donnell, Gavin Falkous, Jennifer A. Moss, J. Beckmann and Margaret A. Johnson and has published in prestigious journals such as The American Journal of Medicine, American Journal Of Pathology and Journal of the Neurological Sciences.

In The Last Decade

Keith Davison

8 papers receiving 650 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Keith Davison United Kingdom	6	630	206	188	187	104	9	665
Marie‐Aline Ludosky France	12	521 0.8×	106 0.5×	163 0.9×	121 0.6×	103 1.0×	15	632
Jim Talbot Canada	2	553 0.9×	95 0.5×	85 0.5×	137 0.7×	141 1.4×	3	593
Michael S. Hudecki United States	13	557 0.9×	74 0.4×	125 0.7×	111 0.6×	195 1.9×	29	653
Yeliz Yuva United Kingdom	8	567 0.9×	202 1.0×	124 0.7×	149 0.8×	51 0.5×	9	653
Jocelyne Léger France	13	431 0.7×	90 0.4×	113 0.6×	290 1.6×	67 0.6×	27	615
J LEGER France	12	362 0.6×	62 0.3×	104 0.6×	172 0.9×	64 0.6×	21	455
Andrée Rouche France	12	462 0.7×	189 0.9×	65 0.3×	128 0.7×	32 0.3×	18	599
M. Chevallay France	15	415 0.7×	88 0.4×	99 0.5×	96 0.5×	59 0.6×	22	481
K Hart United Kingdom	12	703 1.1×	113 0.5×	59 0.3×	182 1.0×	104 1.0×	15	786
J.Rafael M. Gorospe United States	7	429 0.7×	62 0.3×	67 0.4×	70 0.4×	161 1.5×	8	497

Countries citing papers authored by Keith Davison

Since Specialization

Citations

This map shows the geographic impact of Keith Davison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Davison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Davison more than expected).

Fields of papers citing papers by Keith Davison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Davison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Davison. The network helps show where Keith Davison may publish in the future.

Co-authorship network of co-authors of Keith Davison

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Davison. A scholar is included among the top collaborators of Keith Davison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Davison. Keith Davison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Pogue, Robert, Louise V.B. Anderson, Angela Pyle, et al.. (2001). Strategy for mutation analysis in the autosomal recessive limb-girdle muscular dystrophies. Neuromuscular Disorders. 11(1). 80–87. 32 indexed citations

2.

Anderson, Louise V.B., Robert Pogue, Elizabeth Vafiadaki, et al.. (2000). Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies). Neuromuscular Disorders. 10(8). 553–559. 113 indexed citations

3.

Anderson, Louise V.B. & Keith Davison. (1999). Multiplex Western Blotting System for the Analysis of Muscular Dystrophy Proteins. American Journal Of Pathology. 154(4). 1017–1022. 127 indexed citations

4.

Anderson, Louise V.B., Keith Davison, Jennifer A. Moss, et al.. (1998). Characterization of Monoclonal Antibodies to Calpain 3 and Protein Expression in Muscle from Patients with Limb-Girdle Muscular Dystrophy Type 2A. American Journal Of Pathology. 153(4). 1169–1179. 122 indexed citations

5.

Nicholson, L. V. B., Keith Davison, Margaret A. Johnson, et al.. (1989). Dystrophin in skeletal muscle II. Immunoreactivity in patients with Xp21 muscular dystrophy. Journal of the Neurological Sciences. 94(1-3). 137–146. 116 indexed citations

6.

Nicholson, L. V. B., Keith Davison, Gavin Falkous, et al.. (1989). Dystrophin in skeletal muscle I. Western blot analysis using a monoclonal antibody. Journal of the Neurological Sciences. 94(1-3). 125–136. 153 indexed citations

7.

Mantle, David, et al.. (1985). Degradation of naturally occurring peptides by two Ca2+-activated proteinases purified from human skeletal muscle. Biochemical Society Transactions. 13(1). 163–164. 1 indexed citations

8.

Davison, Keith. (1966). Theory of classification : an examination guidebook. 1 indexed citations

9.

Davison, Keith, et al.. (1952). Urinary chromogens in acute porphyria. The American Journal of Medicine. 13(1). 92–92.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact